SE

Karin Malmqvist-Granlund


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Karin Malmqvist-Granlund: Innovator in Pharmaceutical Formulations

Introduction

Karin Malmqvist-Granlund is a notable inventor based in Sweden. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of controlled release dosage forms. His innovative work focuses on enhancing the delivery of pharmacologically active substances.

Latest Patents

Karin Malmqvist-Granlund holds a patent for an "Oral Pharmaceutical Controlled Release Multiple Unit Dosage Form." This invention relates to an oral pharmaceutical multiple units formulation comprising individual cores containing a pharmacologically active substance. The cores are coated with a polymer that is insoluble and impermeable to water and gastrointestinal fluids, along with a water-soluble pore-creating substance. This unique formulation allows for a zero-order diffusion controlled release rate of the active substance. The invention also includes a method for preparing these formulations.

Career Highlights

Throughout his career, Karin has focused on advancing pharmaceutical technologies. His work has been instrumental in developing formulations that improve the efficacy and safety of drug delivery systems. Despite having no patents listed, his contributions to the field are noteworthy.

Collaborations

Karin has collaborated with several professionals in the industry, including Christer Hermansson and Soren Kulstad. These collaborations have helped to enhance the development of innovative pharmaceutical solutions.

Conclusion

Karin Malmqvist-Granlund is a distinguished inventor whose work in pharmaceutical formulations has the potential to impact drug delivery significantly. His innovative approach to controlled release systems showcases the importance of research and development in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…